GAMMAGARD S/D FOR INJECTION
Product details
Registration number: SIN08493P
Classification: Prescription Only
Active ingredients: IMMUNOGLOBULIN G
Strength: 48-56 mg/ml
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
ATC code: J06BA02
HSA approval date: 13 December 1995
Manufacturer(s):
- Baxalta US Inc. (Intermediate)
- Baxalta Belgium Manufacturing S.A.
- Baxter Healthcare Corporation (Diluent)
- Siegfried Hameln GmbH
Manufacturing country/countries: UNITED STATES; BELGIUM; GERMANY
What are the HSA registration number and classification for GAMMAGARD S/D FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN08493P
Classification: Prescription Only
What active ingredients and strength are recorded for GAMMAGARD S/D FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Active ingredients: IMMUNOGLOBULIN G
Strength: 48-56 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for GAMMAGARD S/D FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for GAMMAGARD S/D FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
Which manufacturers and countries are listed for GAMMAGARD S/D FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Baxalta US Inc. (Intermediate)
- Baxalta Belgium Manufacturing S.A.
- Baxter Healthcare Corporation (Diluent)
- Siegfried Hameln GmbH
Manufacturing country/countries: UNITED STATES; BELGIUM; GERMANY
Where can I look up GAMMAGARD S/D FOR INJECTION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN08493P or the exact product name GAMMAGARD S/D FOR INJECTION. The general register link does not preselect this product.
What are the source dates for this GAMMAGARD S/D FOR INJECTION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this GAMMAGARD S/D FOR INJECTION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN08493P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)